Countries and organisations
Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.
Free access · No subscription for research tools or data exports
Explore registry geography and organisations
9 trials match this view; 6 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 329 across 9 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| Consciousness and Psilocybin Effects on Well-Being: The CoPEWell StudyWell-Being, Psychological · Psychedelic Experiences | University of Wisconsin, Madison PHASE1 | Not yet recruiting Registry updated 2026-09-29 | 120 ESTIMATED | 2026-10 2028-02 2028-02 | |
| Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)Psilocybin | University of Wisconsin, Madison PHASE1 | Recruiting Registry updated 2026-08-13 | 60 ESTIMATED | 2025-08-07 2027-12 2027-12 | |
| Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinHealthy · Psychedelic Experiences · Vagus Nerve Stimulation | University of Wisconsin, Madison PHASE1 | Recruiting Registry updated 2026-07-29 | 108 ESTIMATED | 2025-01-27 2027-11 2028-01 | |
| Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone FormulationOpioid Use Disorder | University of Wisconsin, Madison PHASE1 | Recruiting Registry updated 2026-07-07 | 10 ESTIMATED | 2021-01-13 2026-12 2026-12 | |
| Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based SampleMethamphetamine Use Disorder · Substance-Related Disorders · Chemically-Induced Disorders · Substance Use Disorders · Stimulant-Use Disorder | University of Wisconsin, Madison PHASE1 | Terminated Registry updated 2026-05-12 | 5 ACTUAL | 2023-03-03 2024-03-07 2024-03-07 | |
| Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot PhaseHealthy · Psychedelic Experiences · Sleep | University of Wisconsin, Madison PHASE1 | Completed Registry updated 2025-05-16 | 6 ACTUAL | 2023-11-07 2025-02-19 2025-02-19 | |
| Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult VolunteersPsychedelic Experiences · Amnesia | University of Wisconsin, Madison PHASE1 | Completed Registry updated 2023-05-19 | 8 ACTUAL | 2021-05-21 2022-11-17 2022-11-17 | |
| A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral PsilocybinHealthy | University of Wisconsin, Madison PHASE1 | Withdrawn Registry updated 2023-05-15 | 0 ACTUAL | 2023-06 2024-03 2024-03 | |
| Pharmacokinetics of Psilocybin in Normal Adult VolunteersHealthy | University of Wisconsin, Madison PHASE1 | Completed Registry updated 2020-04-15 | 12 ACTUAL | 2014-06 2015-12 2015-12 |
Reported research facilities
This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.